OHR Pharmaceutical Inc Stock Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.63M |
---|---|---|---|---|---|
Net income 2023 * | -12M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on OHR Pharmaceutical Inc
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Director/Board Member | 79 | 19-07-11 |
1st Jan change | Capi. | |
---|---|---|
-0.66% | 41.35B | |
+42.38% | 40.38B | |
+3.39% | 39.05B | |
-12.11% | 26.67B | |
+3.06% | 24.07B | |
-23.32% | 18.36B | |
-2.83% | 11.68B | |
+23.03% | 11.6B | |
+7.64% | 11.15B |